Home › So You Have Lupus, What Now? (Treatment)

So You Have Lupus, What Now? (Treatment)

by Dr. Nazanin Firooz

Lupus, also known as systemic lupus erythematosus (SLE), is a complex and challenging autoimmune disease characterized by inflammation and damage to various organs. While there’s no cure for lupus, effective treatment strategies can significantly improve a patients’ quality of life and prevent disease progression.

Contents [hide]

Therapeutic Goals:

Suppressing inflammation and minimizing immune system overactivity

Managing symptoms and improving quality of life

Preventing organ damage and complications

Tailoring treatment to individual patient needs

Treatment Strategies:

Pharmacological Interventions

Nonsteroidal anti-inflammatory drugs (NSAIDs): Provide relief for pain, swelling, and fever. Examples include ibuprofen and naproxen.

Antimalarials: Suppress inflammation and prevent flares. Hydroxychloroquine (Plaquenil) is the most common choice.

Corticosteroids: Powerful anti-inflammatory medications used to control severe symptoms and flares. Prednisone is a frequently prescribed corticosteroid.

Immunosuppressants

Methotrexate (Rheumatrex, Trexall): An antimetabolite with anti-inflammatory and immunosuppressive properties.

Azathioprine (Imuran): An immunosuppressant that suppresses the immune system by interfering with purine synthesis. Used for managing lupus nephritis and other severe manifestations.

Cyclophosphamide (Cytoxan): A potent immunosuppressant used for severe, life-threatening lupus complications like lupus nephritis or vasculitis. Requires careful monitoring due to potential side effects.

Mycophenolate mofetil (Cellcept): An immunosuppressant that inhibits the proliferation of T and B lymphocytes. Effective for treating lupus nephritis and other organ involvement.

Tacrolimus (Prograf): A calcineurin inhibitor that suppresses T-cell activation. Used for severe lupus cases where other medications are ineffective.

Biologics

Belimumab (Benlysta): A biologic agent that targets B-cell activating factor (BAFF), reducing B cell activity and suppressing autoantibody production.

Anifrolumab (Saphnelo): A monoclonal antibody that targets the interferon-α receptor, offering a novel approach to managing lupus symptoms.

Rituximab (Rituxan): A monoclonal antibody that depletes B cells, leading to reduced autoantibody production and improved disease control.

Lifestyle:

Healthy diet: Focus on a balanced diet rich in fruits, vegetables, whole grains, and lean protein. Limit saturated and processed foods.

Regular exercise: Moderate physical activity improves fitness, reduces stress, and manages fatigue.

Adequate sleep: Aim for 7-8 hours of quality sleep each night.

Stress management: Techniques like yoga, meditation, and deep breathing can help reduce stress levels and improve overall well-being.

Sun protection: Lupus patients are more sensitive to sunlight, so wearing sunscreen with SPF 30 or higher and protective clothing is crucial.

Smoking cessation: Smoking worsens lupus symptoms and increases the risk of complications.

References

van Vollenhoven RF, Mosca M, Bertsias G, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 2014; 73:958.
Bertsias G, Ioannidis JP, Boletis J, et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 2008; 67:195.
Wallace DJ. Improving the prognosis of SLE without prescribing lupus drugs and the primary care paradox. Lupus 2008; 17:91.